China Resources Boya Bio-pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 654.64 million compared to CNY 624.12 million a year ago. Revenue was CNY 654.64 million compared to CNY 624.12 million a year ago. Net income was CNY 103.55 million compared to CNY 100.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.24 a year ago.